News

Medically reviewed by Matthew Wosnitzer, MD Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of ...
Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...
A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...
The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
A group of senior gym-goers who got their prostates checked at roughly the same time were shocked to find almost half of them ...
In a Maple Grove industrial strip mall unequipped with the beanbag chairs common to Silicon Valley startups, Francis Medical ...
A prostate cancer spit test has brought a national screening programme for the disease a step closer, experts have said. The ...
“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in ...
Exercise improved erectile dysfunction compared with standard care among men with prostate cancer, according to study results ...
Historically, prostate cancer was rarely spoken of publicly, often dismissed as a disease of aging. Over time, with advances in screening methods like the PSA (Prostate-Specific Antigen) test, the ...
Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...